Cargando…

Editorial Comment to Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy

Detalles Bibliográficos
Autores principales:	Hirayama, Yukiyoshi, Iguchi, Taro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255293/ https://www.ncbi.nlm.nih.gov/pubmed/34258535 http://dx.doi.org/10.1002/iju5.12344

Ejemplares similares

Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Yoshida, Soichiro, et al.
Publicado: (2021)

Editorial Comment from Dr Hirayama and Dr Iguchi to Cranial nerve palsy caused by metastasis to the skull base in patients with castration‐resistant prostate cancer: Three case reports
por: Hirayama, Yukiyoshi, et al.
Publicado: (2021)

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy
por: Hosogoe, Shogo, et al.
Publicado: (2015)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

Editorial Comment to Microscopic pulmonary tumor embolism from adenocarcinoma of the prostate
por: Iguchi, Taro, et al.
Publicado: (2020)

The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer
por: Tisseverasinghe, Steven A., et al.
Publicado: (2018)

Salvage focal brachytherapy in castration‐resistant prostate cancer with neuroendocrine differentiation after radiation therapy
por: Komori, Takahiro, et al.
Publicado: (2022)

Editorial Comment to Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
por: Tomisaki, Ikko
Publicado: (2022)

Editorial Comment to Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma
por: Uehara, Sho
Publicado: (2020)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Salvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy
por: Chang, Lynn, et al.
Publicado: (2014)

Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer
por: Sekii, Shuhei, et al.
Publicado: (2017)

Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2020)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Editorial Comment on Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer
por: Tanaka, Nobumichi
Publicado: (2022)

Editorial Comment to Castration‐resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy
por: Pennuto, Maria, et al.
Publicado: (2022)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy
por: Verhaegen, Frank, et al.
Publicado: (2020)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

CT-Guided (125)I Seed Interstitial Brachytherapy as a Salvage Treatment for Recurrent Spinal Metastases after External Beam Radiotherapy
por: Yao, Lihong, et al.
Publicado: (2016)

Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
por: Yamamoto, Yoshiyuki
Publicado: (2019)

Editorial Comment
por: Madbouly, Khaled
Publicado: (2011)

EDITORIAL COMMENT
por: Mladenov, Dimitar
Publicado: (2013)

EDITORIAL COMMENT
por: Gibas, Artur
Publicado: (2013)

EDITORIAL COMMENT
por: Salagierski, Maciej
Publicado: (2013)

EDITORIAL COMMENT
por: Tiu, Albert, et al.
Publicado: (2013)

EDITORIAL COMMENT
por: Poletajew, Sławomir, et al.
Publicado: (2013)

EDITORIAL COMMENT
por: Oszukowska, Elżbieta
Publicado: (2013)

EDITORIAL COMMENT
por: Matuszewski, Marcin
Publicado: (2013)

EDITORIAL COMMENT
por: Świniarski, Piotr Paweł
Publicado: (2013)

EDITORIAL COMMENT
por: Apoznański, Wojciech
Publicado: (2013)

Editorial Comment
por: Goel, Apul
Publicado: (2023)

Editorial Comment to Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case
por: Yuasa, Takeshi
Publicado: (2022)

Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019)

Editorial comments: treatment of motor fluctuations in Parkinson’s disease
por: Korczyn, Amos D.
Publicado: (2011)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy
por: Peters, Max, et al.
Publicado: (2016)

A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
por: Yamada, Yoshiya, et al.
Publicado: (2013)

Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
por: Shimizu, Yasuomi, et al.
Publicado: (2018)

Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
por: Korczyn, Amos D.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4jleosab2s3o4g78hie2a4qhq5